Brighton Jones LLC’s GSK GSK Stock Holding History

Brighton Jones LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$464K	Buy	8,857 +1,351	+18%	+$71.5K	0.01%	824
2026 Q1	$414K	Buy	+7,506	New	+$407K	0.01%	777
2025 Q4	–	Sell	-5,749	Closed	-$248K	–	417
2025 Q3	$248K	Sell	5,749 -238	-4%	-$9.3K	0.01%	881
2025 Q2	$230K	Buy	+5,987	New	+$229K	0.01%	819
2025 Q1	–	Sell	-15,604	Closed	-$528K	–	723
2024 Q4	$528K	Buy	+15,604	New	+$562K	0.02%	376
2024 Q3	–	Sell	-6,999	Closed	-$269K	–	617
2024 Q2	$269K	Sell	6,999 -6,137	-47%	-$258K	0.01%	498
2024 Q1	$563K	Buy	+13,136	New	+$542K	0.02%	325
2014 Q3	–	Sell	-4,179	Closed	-$279K	–	210
2014 Q2	$279K	Sell	4,179 -634	-13%	-$42.9K	0.06%	145
2014 Q1	$321K	Sell	4,813 -442	-8%	-$29.9K	0.08%	127
2013 Q4	$351K	Buy	+5,255	New	+$341K	0.08%	121

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Brighton Jones LLC's GSK Position: Q2 2026 in Review

Brighton Jones LLC increased its GSK (GSK) stake by 18% in Q2 2026, buying an estimated $71.5K and bringing the position to 8,857 shares worth $464K. The position accounts for 0.01% of the portfolio, ranked #824.

Brighton Jones LLC first reported a position in GSK in Q4 2013 and has held it in 10 quarters since. The position peaked at $563K in Q1 2024. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Brighton Jones LLC held 8,857 shares of GSK worth $464K as of Q2 2026.
Brighton Jones LLC bought 1,351 GSK shares in Q2 2026, an estimated $71.5K.
GSK made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #824 holding.
Brighton Jones LLC first reported a position in GSK in Q4 2013 and has held it in 10 quarters since.
Brighton Jones LLC's GSK position peaked at $563K in Q1 2024.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.